NEVVI Medicare utilization intelligence
CMS RBCS · Treatments · Treatment - Miscellaneous

Treatment - Miscellaneous — codes without an RBCS family

44 CPT®/HCPCS codes, ranked by est. all-Medicare services — scaled from national Medicare Part B fee-for-service volume. Open any code for the full market view — ranked physician groups, geography, and 12-year trend.

CMS's RBCS classification leaves these codes at the subcategory level — no family is assigned. We list them; we don't invent a family.

CY2024 · National scale is an all-Medicare estimate · est. — scaled estimate — assumes MA utilization mirrors FFS; not an observation; the observed fee-for-service figure is shown adjacent. Part B · national figures

HCPCS · Treatment - Miscellaneous J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg CMS descriptor · HCPCS
Medicare Part B claims
First observed 2018 — first year this code appears in Part B claims
National scale 16.06M services · est. ▲ 16.9% YoY · 26,287 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 7.89M observed fee-for-service services
See the national market for J7345 → ranked groups · states · 12-yr trend
HCPCS · Treatment - Miscellaneous J7336 Capsaicin 8% patch, per square centimeter CMS descriptor · HCPCS
Medicare Part B claims
First observed 2021 — first year this code appears in Part B claims
National scale 5.97M services · est. ▲ 35.0% YoY · 1,585 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 3.06M observed fee-for-service services
See the national market for J7336 → ranked groups · states · 12-yr trend
HCPCS · Treatment - Miscellaneous J3490 Unclassified drugs CMS descriptor · HCPCS
Medicare Part B claims
First observed 2013 — start of our 12-year window; the code predates it
National scale 979,544 services · est. ▲ 5.5% YoY · 82,417 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 485,201 observed fee-for-service services
See the national market for J3490 → ranked groups · states · 12-yr trend
HCPCS · Treatment - Miscellaneous J3590 Unclassified biologics CMS descriptor · HCPCS
Medicare Part B claims
First observed 2013 — start of our 12-year window; the code predates it
National scale 318,685 services · est. ▲ 27.3% YoY · 42,766 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 155,553 observed fee-for-service services
See the national market for J3590 → ranked groups · states · 12-yr trend
HCPCS · Treatment - Miscellaneous G0238 Therapeutic procedures to improve respiratory function, other than described by g0237, one on one, face to face, per 15 minutes (includes monitoring) CMS descriptor · HCPCS
Medicare Part B claims
First observed 2013 — start of our 12-year window; the code predates it
National scale 146,499 services · est. ▲ 35.9% YoY · 714 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 73,069 observed fee-for-service services
See the national market for G0238 → ranked groups · states · 12-yr trend
HCPCS · Treatment - Miscellaneous G0237 Therapeutic procedures to increase strength or endurance of respiratory muscles, face to face, one on one, each 15 minutes (includes monitoring) CMS descriptor · HCPCS
Medicare Part B claims
First observed 2013 — start of our 12-year window; the code predates it
National scale 45,867 services · est. ▲ 14.9% YoY · 1,010 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 22,573 observed fee-for-service services
See the national market for G0237 → ranked groups · states · 12-yr trend
HCPCS · Treatment - Miscellaneous G0239 Therapeutic procedures to improve respiratory function or increase strength or endurance of respiratory muscles, two or more individuals (includes monitoring) CMS descriptor · HCPCS
Medicare Part B claims
First observed 2013 — start of our 12-year window; the code predates it
National scale 15,464 services · est. ▲ 62.9% YoY · 1,548 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 7,483 observed fee-for-service services
See the national market for G0239 → ranked groups · states · 12-yr trend
HCPCS · Treatment - Miscellaneous J9202 Goserelin acetate implant, per 3.6 mg CMS descriptor · HCPCS
Medicare Part B claims
First observed 2013 — start of our 12-year window; the code predates it
National scale 1,000 services · est. ▲ 10.2% YoY · 72 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 499 observed fee-for-service services
See the national market for J9202 → ranked groups · states · 12-yr trend

36 more CPT-coded procedures — shown with a trial or subscription, under AMA licensing.